Torrent Pharmaceuticals allotted 4.19 crore shares to JB Chemicals shareholders on amalgamation
Torrent Pharmaceuticals · Pharmaceuticals & Biotechnology
Key highlights
- Allotment of 4,19,22,416 fully paid-up equity shares of ₹5 each approved on 20th July 2026
- Shares allotted to JB Chemicals shareholders as on record date 17th July 2026 at ratio 51:100
- Issued equity share capital increased from ₹169.22 crore (33.84 crore shares) to ₹190.18 crore (38.04 crore shares)
Why it's rated notable: The allotment completes an NCLT-sanctioned amalgamation dated 6th July, 2026, but the filing states no transaction value, so the level is medium under the no-figure rule.
Figures checked against the filing by a second AI read. About the business, not the share price.
Original filing
Allotment Of 4,19,22,416 Fully Paid-Up Equity Shares Of The Company To The Eligible Shareholders Of J. B. Chemicals & Pharmaceuticals Limited As On The Record Date I.E. 17Th July, 2026, In Terms Scheme Of Amalgamation Of J. B. Chemicals & Pharmaceuticals Limited With Torrent Pharmaceuticals Limited And Their Respective Shareholders
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Torrent Pharmaceuticals
- Acquisition / mergerNotableTorrent Pharmaceuticals completes amalgamation with J. B. Chemicals & Pharmaceuticals
- Acquisition / mergerNotableTorrent Pharmaceuticals receives NCLT order approving J.B. Chemicals merger
- Acquisition / mergerNotableTorrent Pharmaceuticals' Scheme of Amalgamation with J. B. Chemicals sanctioned by NCLT
- Fundraise / allotmentMajor development· Adverse for the businessTorrent Pharmaceuticals audited FY26 results; recommends ₹9 final dividend
- Fundraise / allotmentMajor development· Adverse for the businessTorrent Pharmaceuticals reports audited Q4 and FY26 results, recommends dividend and QIP
Other fundraise / allotment filings this fortnight
- Supreme Engineering allots 14,50,00,000 warrants at ₹2.60 on preferential basis
- Bajaj Finance Limited allots 5.74 crore warrants to Bajaj Finserv on 10 Nov 2026
- Bajaj Finance approves preferential issue of 5.74 crore warrants to Bajaj Finserv
- Chaman Metallics Limited announces H1 FY27 financial results and proposed Rights Issue
- Harmony Capital Services receives BSE approval for preferential issue of shares
- Kuber Udyog: open offer corrigendum, allotments of shares and warrants at ₹23.10
Potential multibaggers · Q2 FY27
Potential multibaggers in Pharmaceuticals & Biotechnology
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.